Connect to other sites within the UBM Medica Network
Resection, Cs131, SBRT All Strong Options for Early-Stage Lung Cancer
A treatment analysis for early NSCLC found that wedge resection, along with Cs131 brachytherapy, and stereotactic body radiation therapy are all strong options.
Evidence Moves OTC Prevention of mCRC Closer to Reality
Ahead of the 2015 ASCO Annual Meeting, we are discussing over-the-counter therapies for patients with metastatic colorectal cancer with Andrew T. Chan, MD, MPH.
Criteria ID’d for Diagnosing Skin Cancer With Reflectance Confocal Microscopy
Researchers have identified several key diagnostic criteria for the diagnosis of melanoma and basal cell carcinoma with reflectance confocal microscopy.
Immunotherapy Effective in Advanced Injectable Melanoma
Researchers have shown for the first time that an oncolytic immunotherapy can have therapeutic benefit in patients with advanced melanoma.
Primary Chemo Good Option in Advanced Ovarian Cancer
A phase III trial found that primary chemotherapy resulted in similar survival compared with primary surgery in newly diagnosed advanced ovarian cancer patients.
CT Screening Now Standard for Those at High Risk for Lung Cancer
In this podcast ahead of the 2015 ASCO Annual Meeting, we discuss CT screening for individuals with a high risk for lung cancer with Claudia I. Henschke, MD, PhD.
Risk Factors for Surgical Complications in Ovarian Cancer
Preoperative albumin level and number of extended cytoreductive procedures in ovarian cancer patients predicted the likelihood of surgical complications.
Slide Show: Adrenal Tumors and Pheochromocytomas
This slide show features adrenocortical carcinomas and adenomas, and various pheochromocytomas at different magnifications.
Slide Show: Pancreatic Neuroendocrine Tumors (PNETs)
This slide show features various magnifications of pancreatic neuroendocrine tumors (PNETs) displaying granular cell-like, clear cell, and other features.
Regorafenib Upped Survival in Asian Patients With Refractory mCRC
The CONCUR trial found that regorafenib improved overall survival in a large group of Asian patients with treatment-refractory metastatic colorectal cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.